Latest

BCG vaccine

·May 19, 2023·5 min read

Is the BCG Vaccine a Potential Shield Against Alzheimer’s?

A recent study suggests that the Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may also reduce the risk of Alzheimer's disease and related dementias. The study followed 6,467 individuals, over 15 years post their diagnosis with non-muscle-invasive bladder cancer. Findings revealed patients who received the BCG vaccine had a 20% lower risk of Alzheimer’s disease and related dementias, and a 25% reduced risk of death.

Featured Neuroscience Open Neuroscience Articles

·April 13, 2020·2 min read

Mandated TB vaccination predicts flattened curves for COVID-19 spread

Researchers report that if the US had adopted mandatory BCG vaccines against tuberculosis decades ago, we may not have reached death rates in triple digits for coronavirus. Countries that have a current policy mandating BCG vaccinations have significantly slower growth of both COVID-19 cases and deaths compared to countries with no mandates for the TB vaccination.

Brain Cancer Featured Neurology Neuroscience Open Neuroscience Articles

·December 26, 2019·3 min read

Tuberculosis vaccine lowers rates of Alzheimer’s disease in cancer patients

The Bacillus Calmette-Guérin (BCG) vaccine, commonly used to innoculate against tuberculosis and as a bladder cancer treatment, also appears to reduce the development of Alzheimer's disease.